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Summary 
Background: Since the cardiovascular (CV) risk score in the
young population, children and adolescents, is underesti-
mated, es pecially in developing countries such as Monte -
negro, where a strong interaction exists between the geneti-
cally conditioned CV risk and environmental factors, the
purpose of this study was to estimate CV risk in apparently
healthy adolescent girls. Moreover, we aimed to test some
new, emerging CV risk factors and their interaction with the
traditional ones, such as obesity. Precisely, we aimed to
assess the impact of low bilirubin levels, as a routine bio-
chemical parameter, as an additional risk factor for athero-
sclerotic disease in the adult phase.
Methods: Forty-five obese adolescent girls (mean age
17.8±1.22 years) and forty-five age- and sex-matched nor-
mal weight controls, all nonsmokers, were included. An -
thro pometric and biochemical parameters were measured.
Cardiovascular Risk Score (CVRS) was calculated by adding
the points for each risk factor (e.g. sex, HDL-c, non-HDL-
c, blood pressure and fasting glycemia).
Results: A significant positive relationship between CVRS
and ALT, hsCRP and TG/HDL-c, but an opposite relation-
ship between CVRS and total bilirubin were found
(P<0.001). Multiple linear regression analysis showed that
Kratak sadr`aj
Uvod: Kako je skor kardiovaskularnog (KV) rizika ~esto pot-
cenjen kod dece i adolescenata, naro~ito u zemljama u
razvoju, kakva je Crna Gora, gde postoji jaka interakcija
izme|u genetski uslovljenog KV rizika i sredine, cilj ove studi-
je je bio da se proceni KV rizik kod zdravih adolescentkinja.
Tako|e, cilj je bio i da se ispitaju neki novi KV faktori rizika u
interakciji sa tradicionalnim, kao {to je gojaznost. Preciznije,
imali smo za cilj da ispitamo uticaj niskih vrednosti bilirubina,
rutinskog biohemijskog parametra, kao dodatnog faktora
rizika za aterosklerozu u adultnom dobu. 
Metode: Ukupno 45 gojaznih adolescentkinja, srednje sta -
rosne dobi 17,8±1,22 godina, i 45 normalno uhranjenih
ado lescentkinja, uparenih po godinama starosti, nepu{a~a,
uklju~eno je u studiju. Mereni su antropometrijski i biohemij -
ski parametri. Skor kardiovaskularnog rizika (CVRS) ra~unat
je dodavanjem poena za svaki faktor rizika (pol, HDL-holes-
terol, non-HDL-holesterol, krvni pritisak i glikemija na{te).
Rezultati: Utvr|ena je statisti~ki zna~ajna pozitivna pove za -
nost izme|u CVRS i ALT, hsCRP i TG/HDL-holesterola
(P<0,001). Vi{estruka linearna regresiona analiza je poka za -
la da su ve}i obim struka i vi{i LDL-holesterol, a ni`i HDL-ho -
lesterol nezavisni prediktori ni`ih vrednosti bilirubina (R2=
0,603, P<0,001).
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Introduction
Traditional coronary heart disease risk factors
are recognized and should be quantified even in chil-
dren and adolescents in order to detect young individ-
uals with a high probability of having increased risk
for cardiovascular disease late in life (1).
The effect of obesity on cardiovascular disease
(CVD) risk often tracks from childhood and adoles-
cence, even if frank heart disease rarely presents be -
fore adulthood (2, 3, 4).
Oxidative stress has appeared in recent years as
a hallmark of the obese state, intrinsically linked to
chro nic low-grade inflammation (5). Hypertrophied
adipocytes have been reported as a significant source
of reactive oxygen species (ROS), promoting adipose
tissue dysfunction by increased expression of adipo -
kines and macrophage infiltration in the adipose tis-
sue, thus further leading to overproduction of ROS
and inflammatory cytokines, and altogether establish-
ing a systematic feedback-loop between inflammation
and oxidative stress in obese adipose tissue (5, 6).
High levels of ROS generated by hypertrophied
adipocytes impact many metabolic signaling path-
ways (e.g., insulin sensitivity, promote inflammation,
and alter lipid metabolism or endothelial dysfunction).
Conversely, vascular damage and inflammation par-
ticipate actively in ROS generation, therefore enter-
taining a vicious circle and maintaining high levels of
oxidative stress, as an important contributor to obesi-
ty-related disorders such as atherosclerosis (5).
Although considered as a harmful metabolite of
heme catabolism, recent findings indicate that serum
bilirubin has antioxidant and antiinflammatory prop-
erties (6). The ability of bilirubin to scavenge reactive
oxygen species (ROS) and to suppress the oxidation
of lipids and lipoproteins, especially low density lipo -
protein (LDL) particles, may be of significant impor-
tance in the pathogenesis of many cardiovascular
(CV) disorders (7, 8). In addition, bilirubin inhibits
tumor necrosis factor-alpha (TNF-a)–induced upre -
gulation of E-selectin, vascular cell adhesion molecule
1 (VCAM-1), and intercellular adhesion molecule 1
(ICAM-1) in vitro (8), thus also showing antiinflamma-
tory properties.
Since cardiovascular risk score in the young pop -
 ulation, children and adolescents is underestimated,
especially in developing countries such as Mon te -
negro, where strong interaction exists between the
genetically conditioned CV risk and environmental
factors, the purpose of this study was to estimate CV
risk in apparently healthy adolescent girls. Moreover,
we wanted to test some new, emerging CV risk factors
and their interaction with the traditional ones, such as
obesity. Precisely, we aimed to assess the impact of a
low bilirubin level, as a routine biochemical parame-
ter, as an additional risk factor for atherosclerotic dis-
ease in the adult phase.
Materials and Methods
Study population
A total of 45 obese adolescent girls, mean age
17.8±1.22 years, and 45 age- and sex-matched nor-
mal weight controls participated in this cross-section-
al study. Participants were selected from two subur-
ban secondary schools in Podgorica, Montenegro and
were recruited in the Primary Health Care Center at
their regular check-up, in the period from December
2012 to March 2013. All the participants completed
a questionnaire including demographic characteris-
tics, somatic illnesses, medication use, and lifestyle
habits. Medical history and clinical examinations were
carried out on the same day.
Inclusion criteria were normal weight and obese,
otherwise healthy adolescent girls between the ages
of 16 and 19. Girls younger than 16 years and older
than 19 years, as well as participants with known liver
dysfunction, diabetes mellitus, renal dysfunction, thy-
roid dysfunction, cardiovascular disorders, with signs
and symptoms of acute inflammatory disease and/or
high sensitivity CRP > 10 mg/L (9), with a history of
alcohol consumption and smoking, and those who
used any medications, were excluded from the study.
Participants were instructed not to perform any vigor-
ous physical activity on the day before the blood was
drawn. All the participants provided written informed
consent, and for those younger than 18 years par-
ents’ written approval was also obtained. The study
protocol was approved by the Ethical Com mittee of
Primary Health Care Center in Pod go rica and the re -
search was carried out in compliance with the De cla -
ration of Helsinki (10).
higher waist circumference (WC) and LDL-c, but lower
HDL-c were independent predictors of lower bilirubin val-
ues (adjusted R2=0.603, P<0.001).
Conclusions: Obese adolescent girls are at an increased
risk of cardiovascular disease late in life. In addition to the
traditional risk factors, total bilirubin may have the potential
to discriminate between low and higher risk for cardiovas-
cular disturbances in healthy adolescent girls.
Keywords: adolescents, cardiovascular risk, inflamma-
tion, obesity, total bilirubin
Zaklju~ak: Gojazne adolescentkinje imaju pove}an rizik za
KV bolesti u kasnijem dobu. Pored tradicionalnih faktora
rizika, ukupni bilirubin mo`e imati potencijal da diskrimini{e
izme|u niskog i ve}eg rizika za KV promene kod zdravih ado-
lescentkinja.
Klju~ne re~i: adolescenti, kardiovaskularni rizik, inflama -
cija, gojaznost, ukupni bilirubin
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Anthropometric measurements
Basic anthropometric measurements: body
height (cm), body weight (kg) and waist circumfer-
ence (WC) (cm) were obtained in the morning.
Weight was measured to the nearest 0.1 kg on a bal-
ance beam scale, with the subjects barefoot and with
light clothing. Height was measured to the nearest
0.1 cm using a wall-mounted stadiometer, without
shoes. Waist circumference was measured with the
nonstretchable tape, over the unclothed abdomen at
the midpoint between the lowest rib and the iliac
crest, and at the end of normal expiration. The tape
was parallel to the floor and did not compress the
skin. Body mass index (BMI) was calculated as weight
in kilograms divided by height in meters squared
(kg/m2). BMI z-score was calculated, also. Using the
World Health Organization (WHO) growth reference,
5–19 years (11) old girls were categorized as normal
weight (-2SD ≤ BMI z-score ≤ +1SD), and overweight
(+1SD < BMI z-score < +2SD) or obese (with BMI
z-score ≥ +2 SD). Blood pressure was measured with
a sphygmomanometer. The average of three mea -
surements taken on the right arm was recorded. All
measurements were taken by the same trained evalu-
ator.
Although our obese group consisted of slightly
obese (overweight, +1SD < BMI z-score < +2SD)
and moderately obese (with BMI z-score ≥ +2 SD)
girls, for simplicity reasons, we referred to them as the
obese participants.
The risk for CVD was estimated using modified
Risk Score for identifying young individuals with a
high probability of having advanced atherosclerotic
lesions, reported by McMahan et al. (1). Cardio vas -
cular Risk Score (CVRS) was calculated by adding the
points for each risk factor (e.g., female sex, HDL-c,
non-HDL-c, smoking, blood pressure and fasting
glycemia) (Table I).
Comparing with the Framingham Risk Score in
adult population, beside the modifiable risk factors
such as blood pressure and HDL-c, we also included
non-HDL-c and fasting glycemia parameters which
can add significant contribution to CV risk assess-
ment. Hypertension was defined as systolic blood
pressure (SBP) or diastolic blood pressure (DBP) ≥
130/85 mm Hg, and hyperglycemia was defined as
fasting glucose ≥ 5.6 mmol/L (12).
Biochemical analyses
The blood samples were taken between 7 and 9
a.m., after 12–14 hours of overnight fasting. Serum
levels of total bilirubin, fasting glucose, alanine
aminotransferase (ALT), total cholesterol (TC), high
density lipoprotein cholesterol (HDL-c), low density
lipoprotein cholesterol (LDL-c) and triglycerides (TG)
were measured spectrophotometrically (Roche Cobas
400, Mann heim, Germany) using standardized enzy-
matic procedures. High sensitivity C-reactive pro tein
(hsCRP) levels were determined using a nephelomet-
ric assay (Behring Nephelometer Analyzer, Marburg,
Germany).
Statistical analysis
Statistical analysis was performed using SPSS
statistical package (version 15.0 for Windows, SPSS,
Chicago, IL, USA). Data are presented as mean ±
standard deviation, median (inter-quartile range), or
counts and percentages. Differences between groups
were evaluated with a Student’s t test for normally,
Mann-Whitney test for non-normally distributed pa -
rameters, or one-way ANOVA, and Kruskal–Wallis
nonparametric analysis of variance where appro -
priate. Chi squared test was used to analyze the dif-
ferences between categorical data. A correlation
analysis, Spearman’s (r) correlation coefficient was
used to determine the relationships between total
bilirubin and other variables. Multiple linear regres-
sion analysis (MLR) was performed to identify inde-
pendent factors affecting serum total bilirubin and to
estimate the final predictors of its variability. Receiver
Operating Characteristic (ROC) curve analysis was
used with the purpose of testing the discriminatory
potential of a group of parameters selected in MLR
analysis, with Risk Score as dependent variable. In all
analyses P value < 0.05 was considered as statistical-
ly significant.
Table I Modified Risk Scores for predicting atherosclerotic














Blood pressure (mm Hg)
Normal 0
High SBP≥130 mm Hg 
and/or DBP≥85 mm Hg 4
Hyperglycemia 
(fasting glucose ≥ 5.6 mmol/L) 5
Results
Table II shows the general clinical and biochem-
ical characteristics of the adolescent girls involved in
this study, divided into normal weight and obese.
Compared with normal weight, obese girls had high-
er anthropometric measures (P<0.001) and lower
HDL-c (P=0.046), as well as total bilirubin level
(P=0.002). They also exhibited higher fasting glu-
cose (P=0.006), non-HDL-c (P=0.014), ALT activity,
hsCRP level (P<0.001, respectively) and blood pres-
sure (P<0.001). No significant difference was found
with respect to age, TC, LDL-c and TG, between
these two groups.
In the current study, we also aimed to test the
association of obesity status, as well as cardiometa-
bolic parameters with the risk for CVD (as estimated
using the modified Risk Score). Therefore, we have
calculated this cardiovascular Risk Score (CVRS) for
every adolescent girl included in the study, and com-
pared the results according to their obesity status.
Obese girls exhibited a significantly higher Risk Score
level than their normal weight counterparts (P<0.001)
(Figure 1).
Additionally, regarding their risk status level, we
divided girls into low, medium and higher risk groups
(-2 ≤ Risk Score ≤ 1, 2 ≤ Risk Score ≤ 4, Risk Score ≥
5, respectively). We found a significantly higher num-
ber of obese girls as compared with normal weight
counterparts in the higher risk group, compared with
low and medium risk groups (c2=15.4, P<0.001).
Moreover, we also found significant difference in sev-
eral parameters, which are independent of the Risk
Score calculation, i.e., significantly higher ALT activi-
ty (P<0.01), hsCRP level (P<0.001), TG/HDL-c ratio
(P<0.01), but lower total bilirubin level in the high
risk group (P<0.001). This part of results is shown in
Table III.
Thereafter, we performed Spearman’s non-
parametric correlation in order to examine the poten-
tial relationship between cardiovascular risk score and
cardiometabolic parameters independent of the Risk
Score calculation (total bilirubin concentration, ALT
activity, hsCRP level and TG/HDL-c ratio in the group
of adolescent girls).
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Table II General characteristics of studied adolescent girls







Age (years) 18.0±0.99 17.7±1.21 0.219
BMI (kg/m2) 21.3±1.84 28.7±3.00 <0.001
BMI z-score –0.03±0.60 1.49±0.33 <0.001
WC (cm) 77.2±5.14 95.6±11.54 <0.001
Fasting glucose
(mmol/L) 5.00±0.38 5.25±0.42 0.006
TC (mmol/L) 4.13±0.59 4.33±0.69 0.245
LDL-c (mmol/L) 2.33±0.54 2.48±0.53 0.199





















SBP (mm Hg) 103±13.2 116±18.4 <0.001
DBP (mm Hg) 68.5±8.70 76.0±11.01 <0.001
Data are presented as mean ± standard deviation or #– data
with non-Gaussian distribution are shown as median values
(interquartile range), or counts and percentages; BMI – body
mass index; WC – waist circumference; TC – total cholesterol;
HDL-c – high density lipoprotein cholesterol; LDL-c – low
density lipoprotein cholesterol; TG – triglycerides; ALT – ala-
nine aminotransferase; hsCRP – high sensitivity C–reactive























Figure 1 Risk score level in obesity status subgroups.












ALT (U/L) 12.1±4.7 20.4±15.1aa 24.8±16.6aaa <0.01
Bilirubin (mmol/L)# 8.20 (6.42–13.27) 5.25 (4.09–7.82)aa 4.20 (3.70–7.13)aa <0.001
hsCRP (mg/L)# 0.47 (0.30–0.71) 1.04 (0.74–3.39)aa 1.55 (0.67–2.30)aa <0.001
TG/HDL-c ratio# 0.50 (0.34–0.80) 0.67 (0.46–1.24)a 0.77 (0.54–1.19)a <0.01











Table III Cardiometabolic parameters independent of Risk Score calculation, in subgroups according to cardiovascular risk level.
a – P<0.05, aa – P<0.01, aaa – P<0.001 vs. Low Risk Score, bbb – P<0.001 vs. Medium Risk Score.
# – data with non-Gaussian distribution are shown as median values (interquartile range) *P value from one-way ANOVA or
Kruskal–Wallis nonparametric analysis of variance, followed by nonparametric Mann–Whitney U test, where appropriate.
Figure 2 Correlation between cardiovascular risk score and total bilirubin, ALT activity, hsCRP level and TG/HDL-c concentration
in a group of adolescent girls.
Spearman’s nonparametric correlation revealed a
significant opposite relationship between CVRS and
bilirubin concentration in the group of adolescent girls
(r=-0.563, P<0.001), and also a positive correlation
of ALT activity (r=0.329, P<0.01), hsCRP level
(r=0.444, P<0.001) and TG/HDL-c ratio (r=0.587,
P<0.001) value with CVRS (Figure 2). 
We conducted a receiver operating characteris-
tic (ROC) analysis of the selected parameters to test
their discriminatory ability regarding Risk Score status
(low vs. higher risk). Additionally, we constructed a
Model consisting of 4 parameters (total bilirubin, ALT,
hsCRP and TG/HDL-c ratio) by using logistic regres-
sion analysis generated predictive probabilities. Figure
3 shows the ROC curve graph and Table IV shows the
most important ROC parameters: area under the
curve (AUC) with the 95% confidence interval (CI) of
selected parameters and the Model. Table IV also
shows sensitivities, specificities and cut-off values for
the selected parameters.
ROC curves comparison showed that all sepa-
rate curves have comparable discriminatory capabili-
ty towards risk level status. Construction of a model
consisting of 4 Risk Score formula independent pa -
rameters (bilirubin, ALT, hsCRP and TG/HDL-c ratio)
by using logistic regression analysis showed that the
new ROC curve had outstanding discriminatory capa-
bility (AUC>0.900, according to Hosmer and Le me -
show’s rules) (13). Model ROC curve has significant-
ly larger AUC than the ROC curve for TG/HDL-c
ratio, hsCRP and ALT alone, respectively. Only total
bilirubin alone has comparable AUC for cardiovascu-
lar discrimination compared to Model ROC (P=
0.055) (Table IV). Because of this potential of total
bilirubin as a routine biochemical parameter to discri -
minate between low and higher risk for cardiovascu-
lar disturbances in an apparently healthy adolescent
female population, further analyses were per formed
focusing on total bilirubin level.
In order to confirm the association of decreased
total bilirubin values with obesity status, as well as with
cardiometabolic risk factors, we divided the patients
according to the tertile values of total bilirubin concen-
tration and counted the number and percentage of
obese subjects. The data are shown in Table V.
Chi-square analysis confirmed that a significant-
ly lower number of obese subjects, as well as a signif-
icantly higher number of normal weight counterparts
were in the group with the highest total bilirubin val-
ues (20%, compared to 40% in the first and second
tertile group, and 44% compared to 27% in the first
and 29% in the second tertile group, respectively,
-c2=6.2, P=0.046). Moreover, with increasing ter-
tiles of serum total bilirubin levels, significant decreas-
es in fasting glucose, lipid parameters (e.g., LDL-c,
TG, non-HDL-c), ALT activity, hsCRP and blood pres-
sure, as well as an increase in HDL-c were found.
The possible relationship between serum total
bilirubin and the clinical and biochemical characteris-











































Figure 3 ROC curves of selected parameters’ discriminatory 
ability regarding cardiovascular Risk Score status (low vs. higher risk).
Table IV Area under the curve, 95% Confidence Interval and Standard Error for the parameters of selected parameters’ discrim-
inatory ability regarding Risk Score status (low vs. higher risk); pairwise comparison of the areas under ROC curves (AUCs) for
Model and separate parameters.
AUC – area under ROC curve; CI – confidence interval; SE – standard error; Model: bilirubin, ALT, hsCRP and TG/HDL-c ratio.
*  – difference between Model ROC and separate parameters.
** – P from pairwise comparison for AUC differences between Model and separate parameters.







Model (4 parameters) 0.911 0.811–1.010 0.051 85 89 / / /
TG/HDL-c ratio 0.722 0.581–0.864 0.072 92 45 0.45 0.189 0.003
hsCRP 0.827 0.695–0.959 0.067 92 60 0.56 0.084 0.018
ALT 0.811 0.683–0.938 0.065 85 65 12.50 0.100 0.049
Bilirubin 0.816 0.696–0.935 0.061 90 62 4.65 0.095 0.055
tics in the group of obese girls was tested with Spear -
man’s nonparametric correlation analysis (Table VI). 
Serum total bilirubin correlated negatively with
anthropometric measures, glucose, lipid parameters
(e.g., LDL-c, TG, TG/HDL-c ratio), ALT, hsCRP, blood
pressure, and positively with HDL-c (Table VI). 
Multiple linear regression (MLR) analysis was
performed to identify which of the measured markers
have the best association with serum total bilirubin
level. Namely, all variables found to have a significant
predictive value in Spearman’s nonparametric corre-
lation (eg., BMI z-score, WC, glucose, HDL-c, LDL-c,
TG, TG/HDL-c ratio, ALT, hsCRP, SBP) were further
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Table V Obesity distribution in total bilirubin tertile values subgroups.
aaa – p<0.001,  aa – p<0.01,  a – p<0.05 vs. third bilirubin tertile; bbb – p<0.001, bb – p<0.01, b – p<0.05 vs. second biliru-
bin tertile.
Data are presented as mean ± standard deviation or # – data with non-Gaussian distribution are shown as median values
(interquartile range), or counts and percentages; *P value from one-way ANOVA or Kruskal–Wallis nonparametric analysis of vari-
ance, followed by nonparametric Mann-Whitney U test, where appropriate; BMI – body mass index; WC – waist circumference;
TC – total cholesterol; HDL-c – high density lipoprotein cholesterol; LDL-c – low density lipoprotein cholesterol; TG – triglycerides;
ALT – alanine aminotransferase; hsCRP – high sensitivity C–reactive protein; SBP – systolic blood pressure; DBP – diastolic blood
pressure.
Obesity status







Age (years) 17.8±1.15 18.2±0.97 17.6±1.13 0.069
BMI (kg/m2) 26.3±4.48aaa 26.2±4.51aaa 22.7±3.40 0.001
BMI z-score 1.01±0.82aaa 0.95±0.81aaa 0.29±0.90 0.002
WC (cm) 92.3±13.88aaa 88.8±12.64aaa 78.8±7.38 <0.001
Glucose (mmol/L) 5.28±0.46aa 5.16±0.33a 4.95±0.40 0.007
TC (mmol/L) 4.31±0.66 4.22±0.62 4.17±0.67 0.685
HDL-c (mmol/L) 1.17±0.18aaa,bbb 1.43±0.28a 1.65±0.41 <0.001
LDL-c (mmol/L) 2.62±0.53aa 2.41±0.43 2.20±0.56 0.007
TG (mmol/L) # 1.07(0.81–1.34)aaa,bb 0.79 (0.54–0.98) 0.64 (0.56–0.84) <0.001
TG/HDL-c ratio # 0.92 (0.72–1.16)aaa 0.49 (0.39–0.64) 0.39 (0.28–0.63) 0.140
Non-HDL-c (mmol/L) 3.14±0.62aaa,b 2.79±0.64 2.51±0.56 0.001
ALT (U/L) # 14.0 (12.0–21.0)aa 12.5 (8.5–17.0) 11.0 (8.5–14.5) 0.012
hsCRP (mg/L) # 0.76 (0.52–2.00)aa 0.67 (0.44–1.30)aa 0.39 (0.18–0.65) 0.002
SBP (mm Hg) 118±19aaa 110±17a 102±12 0.002
DBP (mm Hg) 76.8±12.07aa 71.8±9.35 68.4±8.47 0.006
Obese, n (%) 18 (40) 18 (40) 9 (20) c
2=6.2
P=0.046
Normal weight, n (%) 12 (27) 13 (29) 20 (44)
analyzed in MLR analysis for total bilirubin values pre-
diction. The backward selection enabled us to find
the best model consisting of 3 parameters (e.g., WC
(p<0.001), HDL-c (p<0.001) and LDL-c (p<0.010))
which are shown in Table VII. Adjusted R2 for the best
model was 0.603, which means that 60% of variation
in the total bilirubin level could be explained with this
model.
Discussion
In our study, the risk for CVD was estimated
using modified Risk Score (see Table I) for identifying
young individuals with a high probability of having
advanced atherosclerotic lesions, reported by McMa -
han et al. (1). Compared with the Framingham Risk
Score in the adult population, beside modifiable risk
factors such as blood pressure and HDL-c, we also
included non-HDL-c and fasting glycemia, parame-
ters which can add a significant contribution to the
assessment of CV risk. We found a significantly high-
er number of obese girls as compared with the nor-
mal weight counterparts in the higher risk group,
compared with low and medium risk groups. 
Beside the expected positive relationship be -
tween cardiovascular risk score and ALT activity,
hsCRP level and TG/HDL-c ratio, which are known as
established CV risk factors (9, 14, 15), we also
revealed a significant opposite relationship between
cardiovascular risk score and bilirubin concentrations
in the group of adolescent girls (Figure 2). Therefore,
we conducted a ROC analysis of selected parameters
to test their discriminatory ability re garding Risk Score
status (low vs. higher risk). Addi tio nally, construction
of a model consisting of 4 Risk Score formula inde-
pendent parameters (bili ru bin, ALT, hsCRP and TG/
HDL-c ratio) by using lo gi stic regression analysis
show ed that the new comprehensive ROC curve (Fi -
gure 3) has outstanding discri mi natory capability (11).
We showed that Model ROC curve had significantly
larger AUC than ROC for TG/HDL-c ratio, hsCRP and
ALT alone, respectively, and only total bilirubin alone
had a comparable AUC for cardiovascular discrimina-
tion compared to Model ROC (Table IV). 
This potential of total bilirubin as a routine bio-
chemical parameter to discriminate between low and
higher risk for cardiovascular disturbances in an ap -
parently healthy adolescent female population is the
novel finding in our study.
The results of studying individuals with benign
hyperbilirubinemia (Gilbert’s syndrome – GS) have
greatly added to the exploration of the physiological
protective effects of bilirubin, showing that GS indi-
viduals are at decreased risk of CVD (7).
Since only girls were included in our study, and
all were nonsmokers, we reported lower score values
than the previous study conducted by McMahan et al.
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Table VI Spearman’s nonparametric corre lation between
serum total bilirubin concentration and clinical variables in
obese adolescent girls.
Table VII Multiple linear regression standardized β coeffi-
cients, 95% Confidence Interval and P values for the param-
eters in the best-fit model for the association of several
parameters with serum total bilirubin levels, backward selec-
tion.
Variable r P
Age (years) –0.069 0.648 
BMI (kg/m2) –0.357 0.018
BMI z-score –0.352 0.019 
WC (cm) –0.601 <0.001
Fasting glucose (mmol/L) –0.458 0.002
TC (mmol/L) –0.016 0.916 
HDL-c (mmol/L) 0.530 <0.001
LDL-c (mmol/L) –0.328 0.029
TG (mmol/L) –0.495 0.001
ALT (U/L) –0.383 0.011
hsCRP (mg/L) –0.498 0.001
TG/HDL-c ratio –0.556 <0.001
Non-HDL-c (mmol/L) –0.258 0.087
SBP (mm Hg) –0.417 0.006
DBP (mm Hg) –0.385 0.011
BMI – Body mass index; WC – waist circumference; TC – total
cholesterol; HDL-c – high density lipoprotein cholesterol;
LDL-c – low density lipoprotein cholesterol; TG – trigly -
cerides; ALT – alanine aminotransferase; hsCRP – high sen-
sitivity C – reactive protein; TG/HDL-c – triglycerides – high
density lipoprotein cholesterol ratio; non-HDL-c–non – high
density lipoprotein cholesterol.
WC – waist circumference; HDL-c – high density lipoprotein
cholesterol; LDL-c – low density lipoprotein cholesterol.
Coefficients
Standardized
Coefficients   
95% Confidence
Interval for b P
WC –0.4 –0.192–0.064 <0.001
HDL-c 0.4 2.186–6.432 <0.001
LDL-c –0.3 –3.033–0.434 <0.010
(1). Moreover, they emphasized that although the
girls reported to have increased cardiovascular risk
relative to their low risk counterparts, the probability
of atherosclerotic lesions in young persons (aged
16–19 years) is certainly low at present, but in older
persons, when contributions of age are included with
risk due to similar values of the modifiable risk factors
as in the period of adolescence, the probability of ves-
sel wall lesions may be greatly increased (1).
Tatami et al. (16) demonstrated an independent
association of low serum bilirubin levels with severe
carotid atherosclerosis in coronary artery disease
(CAD) patients. In line with these results, Song et al.
(17) in a prospective Korean cohort during a 4-year
follow-up showed that the lowest serum total bilirubin
level category (bilirubin ≤ 5.47 mmol/L) was an inde-
pendent risk factor for future CAD events. 
On the contrary, Jørgensen et al. (18), in a study
including almost 10.000 overweight/obese patients
with high cardiovascular risk, showed that low biliru-
bin was not a risk factor independent of other tradi-
tional cardiovascular risk factors. Even though they
showed a trend towards lower risks associated with
increased bilirubin levels, after adjustment for classi-
cal cardiovascular risk factors (e.g., blood pressure,
lipids, BMI, smoking, microalbuminuria), the lower
risk of CVD in subjects with bilirubin values higher
than 8 mmol/L compared to bilirubin levels ≤ 8
mmol/L was no longer statistically significant. Addi -
tional adjustment for liver function indicators did not
alter the results, suggesting that low bilirubin may not
be an independent risk marker for CVD in this cohort
of patients with high baseline risk of adverse cardio-
vascular outcomes.
In our study, lower serum bilirubin levels were
related to higher anthropometric indices and unfavor-
able cardiometabolic markers in obese adolescent
girls. Moreover, multiple linear regression analysis
showed that higher WC and LDL-c, but lower HDL-c,
the well-known, established cardiovascular risk factors
were found to be independent predictors of lower
total bilirubin levels. This may be explained by the
notion that bilirubin has antioxidant and antiinflam-
matory properties (7). Under normal concentrations,
unbound bilirubin has scavenging properties to sin-
glet oxygen. In the presence of hydrogen peroxide
bilirubin acts as a reducing agent (19). Namely, un -
der oxidative stress (which plays an important role in
atherosclerosis development) one of the protective
agents is the hemeoxygenase (HO) which reduces
cytotoxic effects and degrades atherogenic heme into
biliverdin, carbon monoxide (CO), and Fe+2 (20).
The former is then converted into bilirubin by the
activity of bilirubin reductase on biliverdin. Substrate
heme is highly reactive and cytotoxic in its unbound
form, whereas CO and bilirubin are recognized as
mediators that, in the case of CO, inhibit inflammato-
ry processes, and, in the case of bilirubin, scavenge
free radicals by inhibiting NADPH oxidase (21).
Here, obese adolescent girls exhibited lower
serum total bilirubin levels as compared with the nor-
mal weight counterparts. This is in accordance with
the results by Jenko-Pra`nikar et al. (22) who report-
ed lower total bilirubin levels in healthy overweight
nonsmoking middle-aged adults of both sexes. Belo
et al. (23) reported an inverse correlation between
body fat percentage and total bilirubin in obese chil-
dren and adolescents. We also confirmed the inverse
relationship between serum total bilirubin level and
unfavorable lipid profile including higher LDL-c and
TG, but a positive relationship with HDL-c. This is in
accordance with previous results (22, 24), thus sug-
gesting that bilirubin may act as a physiological
hypolipidemic agent that protects from CVD (25).
However, only one study reported decreasing HDL-c
concentrations with an increasing bilirubin level (26).
Further, we reported a significant inverse correlation
between total bilirubin and the proatherogenic, com-
prehensive markers of lipid status, such as non-HDL-
c and TG/HDL-c ratio. Inverse relationship between
bilirubin and non-HDL cholesterol was recently
shown in a study by McArdle et al. (27). Moreover, to
our knowledge, this is the first study examining the
potential relationship between total bilirubin and
TG/HDL-c ratio. Namely, TG/HDL-c ratio, an esti-
mate of small, dense low-density lipoprotein particles,
is an independent determinant of arterial stiffness in
adolescents and young adults, especially in obese
youth, suggesting that the use of TG/HDL-c ratio may
be helpful in identifying young adults requiring
aggres sive intervention to prevent atherosclerotic
CVD (15). This could be another confirmation of the
close relationship between total bilirubin level and CV
risk in the adolescent population.
Furthermore, in agreement with the notion that
higher bilirubin levels may contribute to reduced sys-
temic low-grade inflammation, some studies (23, 28)
have shown an inverse relationship of hsCRP with
serum total bilirubin. Our results also confirmed the
negative correlation between total bilirubin level and
hsCRP, but it was not independent of other traditional
CV factors. 
The ability of bilirubin to scavenge ROS and to
inhibit low density lipoprotein (LDL) oxidation (7, 8)
may be of significant importance in the pathogenesis
of many cardiovascular disorders characterized by
enhanced systemic low-grade inflammation and/or
increased oxidative stress. Limitations of the present
study must be considered. Due to its cross-sectional
design, a causal relationship between total bilirubin,
anthropometric and cardiometabolic markers could
not be established. It should also be emphasized that
the small number of participants is a limitation for a
study dealing with cardiovascular risk estimation.
How ever, to get better insight into the association
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between total bilirubin and obesity-related disorders,
we examined a broad spectrum of biochemical pa -
rameters that may be important determinants of car-
diometabolic disturbances. Thus, despite the limited
size of cohorts, the findings of the present study sup-
port the hypothesis that lower circulating total biliru-
bin could reflect an unfavorable cardiometabolic pro-
file in obese adolescent girls.
Conclusion
Obese adolescent females are at increased risk
of cardiovascular disease. In addition to traditional
risk factors, total bilirubin level may have the potential
to discriminate between low and higher risk for car-
diovascular disturbances in an apparently healthy ado -
 lescent female population. Furthermore, serum total
bilirubin level is significantly decreased in obese ado-
lescent girls and the constellation of increased WC
and LDL-c and decreased HDL-c was an independent
predictor of its lower values. Prospective studies are
needed to clarify the potential role of total bilirubin in
obesity-related disorders which may lead to the dis-
covery of new target therapy used to induce the pro-
tective effects of bilirubin in individuals at in creased
risk of CVD.
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